BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24581457)

  • 1. Radiofrequency ablation for ground-glass opacity-dominant lung adenocarcinoma.
    Kodama H; Yamakado K; Hasegawa T; Takao M; Taguchi O; Fukai I; Sakuma H
    J Vasc Interv Radiol; 2014 Mar; 25(3):333-9. PubMed ID: 24581457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous radiofrequency ablation of lung cancer presenting as ground-glass opacity.
    Iguchi T; Hiraki T; Gobara H; Fujiwara H; Matsui Y; Soh J; Toyooka S; Kiura K; Kanazawa S
    Cardiovasc Intervent Radiol; 2015 Apr; 38(2):409-15. PubMed ID: 24938905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance.
    Hess A; Palussière J; Goyers JF; Guth A; Aupérin A; de Baère T
    Radiology; 2011 Feb; 258(2):635-42. PubMed ID: 21273525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transosseous Route for CT Fluoroscopy-Guided Radiofrequency Ablation of Lung Tumors.
    Iguchi T; Hiraki T; Ishii H; Gobara H; Fujiwara H; Matsui Y; Kanazawa S
    J Vasc Interv Radiol; 2015 Nov; 26(11):1694-8. PubMed ID: 26432461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.
    Suh RD; Wallace AB; Sheehan RE; Heinze SB; Goldin JG
    Radiology; 2003 Dec; 229(3):821-9. PubMed ID: 14657317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresectable Adrenal Metastases: Clinical Outcomes of Radiofrequency Ablation.
    Hasegawa T; Yamakado K; Nakatsuka A; Uraki J; Yamanaka T; Fujimori M; Miki M; Sasaki T; Sakuma H; Sugimura Y
    Radiology; 2015 Nov; 277(2):584-93. PubMed ID: 25997031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.
    Yamanaka T; Takaki H; Nakatsuka A; Uraki J; Fujimori M; Hasegawa T; Sakuma H; Yamakado K
    J Vasc Interv Radiol; 2013 Mar; 24(3):341-6. PubMed ID: 23352855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
    Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW
    Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
    Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
    J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
    Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
    Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unresectable lung malignancy: combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients.
    Gadaleta CD; Solbiati L; Mattioli V; Rubini G; Fazio V; Goffredo V; Vinciarelli G; Gadaleta-Caldarola G; Canniello E; Armenise F; D'Aluisio L; Gaudiano A; Ranieri G; Goldberg SN
    Radiology; 2013 May; 267(2):627-37. PubMed ID: 23249572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
    de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
    Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
    Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation of lung metastases from adenoid cystic carcinoma of the head and neck: retrospective evaluation of nine patients.
    Iguchi T; Hiraki T; Gobara H; Fujiwara H; Matsui Y; Toyooka S; Nishizaki K; Kanazawa S
    J Vasc Interv Radiol; 2015 May; 26(5):703-8. PubMed ID: 25655029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected].
    Nakamura T; Matsumine A; Yamakado K; Matsubara T; Takaki H; Nakatsuka A; Takeda K; Abo D; Shimizu T; Uchida A
    Cancer; 2009 Aug; 115(16):3774-81. PubMed ID: 19514086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for lung tumors: outcomes, effects on survival, and prognostic factors.
    Akhan O; Güler E; Akıncı D; Çiftçi T; Köse IÇ
    Diagn Interv Radiol; 2016; 22(1):65-71. PubMed ID: 26611111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous radiofrequency ablation for pulmonary metastases from esophageal cancer: retrospective evaluation of 21 patients.
    Matsui Y; Hiraki T; Gobara H; Fujiwara H; Iguchi T; Shirakawa Y; Fujiwara T; Toyooka S; Kanazawa S
    J Vasc Interv Radiol; 2014 Oct; 25(10):1566-72. PubMed ID: 25156828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients.
    Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
    J Vasc Interv Radiol; 2007 Oct; 18(10):1264-9. PubMed ID: 17911517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention.
    Kodama H; Yamakado K; Takaki H; Kashima M; Uraki J; Nakatsuka A; Takao M; Taguchi O; Yamada T; Takeda K
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):563-9. PubMed ID: 21748451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency Ablation Using a Multiple-Electrode Switching System for Lung Tumors with 2.0-5.0-cm Maximum Diameter: Phase II Clinical Study.
    Kodama H; Yamakado K; Hasegawa T; Fujimori M; Yamanaka T; Takaki H; Uraki J; Nakatsuka A; Sakuma H
    Radiology; 2015 Dec; 277(3):895-902. PubMed ID: 26053308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.